Showing results (251-260 of 345) with videos related to

Sort By:
Pageof 35
The Journal of Clinical Endocrinology and Metabolism|April 17, 2008
Low circulating insulin-like growth factor I bioactivity in elderly men is associated with increased mortalityM P Brugts, A W van den Beld, L J Hofland, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 7, 2003
Crucial role for somatostatin receptor subtype 2 in determining the uptake of [111In-DTPA-D-Phe1]octreotide in somatostatin receptor-positive organsLeo J Hofland, Steven W J Lamberts, P Martin van Hagen, et al.
Clinical Endocrinology|August 19, 2011
Balance between somatostatin and D2 receptor expression drives TSH-secreting adenoma response to somatostatin analogues and dopastatinsFederico Gatto, Federica Barbieri, Monica Gatti, et al.
European Journal of Endocrinology|February 9, 2002
Ghrelin drives GH secretion during fasting in manAlex F Muller, Steven W J Lamberts, Joop A M J L Janssen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1997
In vitro and in vivo detection of functional somatostatin receptors in canine insulinomasJ H Robben, H A Visser-Wisselaar, G R Rutteman, et al.
American Journal of Physiology. Endocrinology and Metabolism|January 15, 2009
Effects of type I interferons on IGF-mediated autocrine/paracrine growth of human neuroendocrine tumor cellsGiovanni Vitale, Peter M van Koetsveld, Wouter W de Herder, et al.
Endocrine-Related Cancer|April 3, 2019
Effects of novel somatostatin-dopamine chimeric drugs in 2D and 3D cell culture models of neuroendocrine tumorsAura D Herrera-Martínez, Rosanna van den Dungen, Fadime Dogan-Oruc, et al.
Lung Cancer (Amsterdam, Netherlands)|June 5, 2017
The components of somatostatin and ghrelin systems are altered in neuroendocrine lung carcinoids and associated to clinical-histological featuresAura D Herrera-Martínez, Manuel D Gahete, Rafael Sánchez-Sánchez, et al.
Pageof 35